Beta
387193

Exploring the Adverse Impacts of Cyclosporine A and the Preventative Abilities of Moringa oleifera Seed Oil: A Therapeutic Approaches Contrary to Negative Effects

Article

Last updated: 01 Jan 2025

Subjects

-

Tags

Biochemistry

Abstract

Cyclosporine A (CsA) is a popular immunosuppressive medication for organ transplant recipients which its injection associated with oxidative stress. Moringa oleifera Seed oil (MOO) own high biological active ingredients, which makes it valuable medicinal plant-based dietary supplement that is used to address various nutrition-related wellness issues. The research is targeted to figure out the protective ability of MOO and encapsulated MOO (EMOO) against CsA toxicity, and assessing their antioxidant and anti-inflammation qualities. Rats (n=24) were separated into four groups: (1) received distilled water (control); (2) rats injected by CsA, (3) and (4) received MOO and EMOO coupled with CsA for 8 weeks. The oxidation, inflammation and minerals indices were measured in serum, liver and bone. Administration of MOO or EMOO significantly inhibited the development of bone loss in femur and tibia, improved hepatic and renal function, alleviate oxidative damage and inflammation compared to CsA rats. The histopathological examination of hepatic- and splenic tissue of MOO or EMOO showed improvement in tissue structure compared to CsA rats tissues. Encapsulating-MOO showed more effectiveness impact than MOO against CsA toxicity. Considering the potential antioxidant and anti-inflammatory characteristics of MOO, this research highlights its potential as a complementary therapeutic option when undergoing cyclosporine A.

DOI

10.21608/ejchem.2024.320114.10402

Keywords

Moringa seed oil - Cyclosporine A, encapsulation - Antioxidant, Anti inflammation

Authors

First Name

Kadry

Last Name

Ghanem

MiddleName

Z.

Affiliation

Nutrition and Food Sciences Department, National Research Centre, Giza, Egypt.

Email

kadryghanem2013@gmail.com

City

Cairo

Orcid

0000-0003-0922-3983

First Name

Manal

Last Name

Ramadan

MiddleName

M.

Affiliation

Chemistry of Flavour & Aroma Department, National Research Centre, Giza, Egypt.

Email

manal.nrc88@gmail.com

City

Cairo

Orcid

0000-0001-9908-5363

First Name

Rasha

Last Name

Mohamed

MiddleName

S.

Affiliation

Nutrition and Food Sciences Department, National Research Centre, Giza, Egypt.

Email

smarasha2005@yahoo.com

City

cairo

Orcid

0000-0003-4223-000X

First Name

Ola A.M.

Last Name

Mohawed

MiddleName

-

Affiliation

Hormones Department, National Research Centre Giza, Egypt.

Email

olamhawed@yahoo.com

City

Cairo

Orcid

0000-0003-4080-572X

First Name

Noha N.

Last Name

Yassen

MiddleName

-

Affiliation

Pathology Department, National Research Centre, Giza, Egypt

Email

noha.nazeeh@gmail.com

City

-

Orcid

-

First Name

Sahar A.

Last Name

Abdel-Aziz

MiddleName

-

Affiliation

Nutrition and Food Sciences Department, National Research Centre, Giza, Egypt.

Email

saharabdelaziz15@yahoo.com

City

-

Orcid

0009-0003-4726-8143

First Name

Entsar N.

Last Name

Mohamed

MiddleName

-

Affiliation

Food Engineering and Packaging Department, Agricultural Research Center, Giza, Egypt

Email

entnour@gmail.com

City

GIZA

Orcid

0000-0003-0777-9793

Volume

67

Article Issue

12

Related Issue

50716

Issue Date

2024-12-01

Receive Date

2024-09-11

Publish Date

2024-12-01

Page Start

387

Page End

397

Print ISSN

0449-2285

Online ISSN

2357-0245

Link

https://ejchem.journals.ekb.eg/article_387193.html

Detail API

https://ejchem.journals.ekb.eg/service?article_code=387193

Order

387,193

Type

Original Article

Type Code

297

Publication Type

Journal

Publication Title

Egyptian Journal of Chemistry

Publication Link

https://ejchem.journals.ekb.eg/

MainTitle

Exploring the Adverse Impacts of Cyclosporine A and the Preventative Abilities of Moringa oleifera Seed Oil: A Therapeutic Approaches Contrary to Negative Effects

Details

Type

Article

Created At

30 Dec 2024